Creating a tissue bank for parathyroid disease
Establishment of a Parathyroid Tissue Bank
This study is creating a tissue bank to collect samples from patients with parathyroid disease to help researchers find better ways to treat this condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT03051126 on ClinicalTrials.gov |
What this trial studies
This project aims to establish a tissue bank library for patients with parathyroid disease who have undergone surgical procedures or biopsies. The bank will collect both normal and diseased parathyroid tissue samples, as well as blood samples, to facilitate ongoing research into parathyroid disease management. Samples will be obtained during surgical interventions and from patients at participating sites, with collections potentially spanning up to fifteen years. The initiative seeks to enhance understanding and treatment options for parathyroid conditions.
Who should consider this trial
Good fit: Ideal candidates include patients scheduled for surgical treatment of parathyroid disease or those with MEN1 and related conditions.
Not a fit: Patients who do not have parathyroid disease or are not undergoing surgical intervention may not benefit from this study.
Why it matters
Potential benefit: If successful, this tissue bank could significantly advance research and treatment strategies for patients with parathyroid disease.
How similar studies have performed: Other studies involving tissue banks for various diseases have shown success in advancing research, indicating a promising approach for this initiative.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Eligible participants will include patients presenting at MD Anderson Cancer who are scheduled for surgical treatment of parathyroid disease and/or patients with MEN1, and/or those presenting with hyperparathyroidism and/or pancreatic lesion, who are scheduled for pancreas tumor intervention, as well as patients having had surgery and who have had residual tissue stored under LAB02-518, LAB03-0320 or prior front door consents, or who have had surgery at other centers and provide signed authorization to obtain the tissue from the outside institution. 2. In addition, eligible participants may include family members of MD Anderson patients who have been diagnosed with parathyroid disease and who have had surgery at other centers, and who provide a signed authorization to obtain the tissue from outside facilities AND/OR who begin care at MD Anderson and will be having intervention at MD Anderson. Exclusion Criteria: N/A
Where this trial is running
Houston, Texas
- University of Texas MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Nancy D. Perrier, MD — M.D. Anderson Cancer Center
- Study coordinator: Nancy D. Perrier, MD
- Email: NPerrier@mdanderson.org
- Phone: 713-792-6940
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.